Search

everythinglearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

New acne treatments show promise as alternatives to traditional therapies.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Estrogen affects hair growth and skin cell multiplication.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Caffeine-based liquid 0.2% is as effective as minoxidil 5% for treating male hair loss.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.